MyFinsight
Home
Blog
About
CI_BIG
Cigna Group (CI)
CI_BIG
Cigna Group (CI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net income
Accounts payable and accrued exp...
Net change in short-term debt
Others
Negative Cash Flow Breakdown
Accounts receivable, net
Reinsurance recoverable and othe...
Common stock dividend paid
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
1,875
1,861
1,274
1,973
Depreciation and amortization
655
650
722
697
Investment gains, net
-69
258
-100
26
Deferred income tax benefit
110
60
-500
-118
Gain on sale of businesses
6
11
-66
38
Accounts receivable, net
4,196
-2,152
-2,281
513
Inventories
17
-1,507
1,706
-334
Reinsurance recoverable and other assets
502
-104
360
135
Insurance liabilities
167
739
-415
-40
Pharmacy and other service costs payable
462
-4,570
31
842
Accounts payable and accrued expenses and other liabilities
1,218
-988
3,654
163
Other, net
36
-5
-2
-43
Net cash provided by operating activities
-421
1,131
6,149
3,418
Proceeds From Sale Of
50
54
264
246
Proceeds From Maturities Prepayments And Calls Of
214
185
241
192
Proceeds From Collection Of Loans
73
2
25
108
Other sales, maturities and repayments (primarily short-term and other long-term investments)
87
426
228
225
Payments To Acquire
306
362
517
3,759
Payments To Acquire Mortgage Notes
1
39
0
55
Other (primarily short-term and other long-term investments)
192
557
350
305
Property and equipment purchases, net
297
267
322
278
Acquisitions, net of cash acquired
-
-
0
597
Divestitures, net of cash sold
6
20
638
0
Renewable energy tax credit equity investments
120
94
617
158
Other, net
17
5
10
6
Net cash (used in) provided by investing activities
-503
-637
-420
-4,387
Deposits and interest credited to contractholder deposit funds
35
39
39
39
Withdrawals and benefit payments from contractholder deposit funds
59
99
52
64
Net change in short-term debt
988
-13
-12
-1,211
Net proceeds on issuance of term loan
-
-
0
1,999
Repayment of term loan
-
-
0
2,000
Repayment of long-term debt
0
550
2,554
43
Net proceeds on issuance of long-term debt
-
-
-3
4,461
Repurchase of common stock
280
0
1,001
0
Issuance of common stock
101
57
25
37
Common stock dividend paid
409
417
396
402
Other, net
-169
-158
-112
-157
Net cash used in financing activities
207
-1,141
-4,066
2,659
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash
-7
-9
2
-5
Net decrease in cash, cash equivalents and restricted cash
-724
-656
1,665
1,685
Cash, cash equivalents and restricted cash january 1, including held for sale assets
-
-
8,376
8,376
Cash, cash equivalents and restricted cash december 31, including held for sale assets
-
-
7,736
6,071
Cash and cash equivalents reclassified to assets of businesses held for sale
-
-
0
0
Cash, cash equivalents and restricted cash and cash equivalents january 1,
7,080
7,736
-
-
Cash, cash equivalents and restricted cash, end of year
6,356
7,080
7,736
6,071
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in
short-term debt
$988M
(-16.76%↓ Y/Y)
Issuance of common stock
$101M
(40.28%↑ Y/Y)
Deposits and interest
credited to...
$35M
(-7.89%↓ Y/Y)
Net cash used in
financing activities
$207M
(115.53%↑ Y/Y)
Canceled cashflow
$917M
Net decrease in
cash, cash...
-$724M
(81.85%↑ Y/Y)
Canceled cashflow
$207M
Proceeds From Maturities
Prepayments And Calls Of
$214M
(-35.35%↓ Y/Y)
Other sales,
maturities and repayments...
$87M
(-13.00%↓ Y/Y)
Proceeds From Collection
Of Loans
$73M
(1360.00%↑ Y/Y)
Proceeds From Sale Of
$50M
(-71.91%↓ Y/Y)
Divestitures, net of cash sold
$6M
Net income
$1,875M
(14.89%↑ Y/Y)
Accounts payable and
accrued expenses and...
$1,218M
(690.91%↑ Y/Y)
Depreciation and
amortization
$655M
(-3.96%↓ Y/Y)
Pharmacy and other
service costs payable
$462M
(-46.28%↓ Y/Y)
Insurance liabilities
$167M
(319.74%↑ Y/Y)
Investment gains, net
-$69M
(-232.69%↓ Y/Y)
Common stock dividend
paid
$409M
(2.00%↑ Y/Y)
Repurchase of common stock
$280M
(-74.82%↓ Y/Y)
Other, net
-$169M
(-17.36%↓ Y/Y)
Withdrawals and benefit
payments from...
$59M
(-19.18%↓ Y/Y)
Net cash (used in)
provided by investing...
-$503M
(36.89%↑ Y/Y)
Net cash provided by
operating activities
-$421M
(77.68%↑ Y/Y)
Canceled cashflow
$430M
Canceled cashflow
$4,446M
Effect of foreign
currency rate changes on...
-$7M
(-126.92%↓ Y/Y)
Payments To Acquire
$306M
(-45.36%↓ Y/Y)
Property and equipment
purchases, net
$297M
(4.21%↑ Y/Y)
Accounts receivable, net
$4,196M
(0.07%↑ Y/Y)
Other (primarily
short-term and other...
$192M
(-32.87%↓ Y/Y)
Renewable energy tax
credit equity...
$120M
(-48.94%↓ Y/Y)
Other, net
$17M
(0.00%↑ Y/Y)
Payments To Acquire
Mortgage Notes
$1M
(-96.43%↓ Y/Y)
Reinsurance recoverable and
other assets
$502M
(174.32%↑ Y/Y)
Deferred income tax
benefit
$110M
(44.74%↑ Y/Y)
Other, net
$36M
(122.93%↑ Y/Y)
Inventories
$17M
(-97.85%↓ Y/Y)
Gain on sale of
businesses
$6M
Buy us a coffee